These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
506 related items for PubMed ID: 17165432
1. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies. Growdon WB, Wolfberg AJ, Feltmate CM, Goldstein DP, Genest DR, Chinchilla ME, Berkowitz RS, Lieberman ES. J Reprod Med; 2006 Nov; 51(11):871-4. PubMed ID: 17165432 [Abstract] [Full Text] [Related]
2. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy. Wolfberg AJ, Berkowitz RS, Goldstein DP, Feltmate C, Lieberman E. Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585 [Abstract] [Full Text] [Related]
9. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation. Braga A, Maestá I, Matos M, Elias KM, Rizzo J, Viggiano MG. Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828 [Abstract] [Full Text] [Related]
10. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease. Thomas CM, Kerkmeijer LG, Ariaens HJ, van der Steen RC, Massuger LF, Sweep FC. Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088 [Abstract] [Full Text] [Related]
12. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia. Cole LA, Butler SA, Khanlian SA, Giddings A, Muller CY, Seckl MJ, Kohorn EI. Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241 [Abstract] [Full Text] [Related]